News

Call for Abstracts and Society Prize Submissions for the Anti-NMDA Receptor Encephalitis Foundation Prize 2022. From www.antinmdafoundation.org - January 16, 5:45 PM Once again, the Canadian Neurological Sciences Federation (CNSF) is calling for submissions of Abstracts and Society prize submissions…

Once again, the Canadian Neurological Sciences Federation (CNSF) is calling for submissions of Abstracts and Society prize submissions by or before 31 January 2022. The CNSF is an umbrella organisation comprised of six societies representing the field of neurology in…

Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy | Neurology Neuroimmunology & Neuroinflammation From nn.neurology.org - January 6, 6:26 PM Except for the high frequency of patients in the age ≥45 years, our cohort showed…

Dear Subscriber, We are nearing the end of 2021 and we look forward to bringing you more of the very best from the medical literature on anti-NMDA receptor encephalitis and autoimmune encephalitis in 2022. We hope you have found our…

BREAKING NEWS! First Clinical Trial for Anti-NMDA Receptor Encephalitis From mailchi.mp - December 3, 10:26 PM In the spring of 2020, the Foundation expressed its strong support for the first-ever Clinical Trial for a promising new drug to treat anti-NMDA…

ICYMI, please find a link to the Breaking News Announcement, regarding the ExTINGUISH Clinical Trial which we made on December 1, 2021. Today, we are pleased to provide you with some Frequently Asked Questions regarding the ExTINGUISH Trial: Frequently Asked…

FYI, there are only two PAO’s that are official partners of the ExTINGUISH Trial. They are the Anti-NMDA Receptor Encephalitis Foundation and the Autoimmune Encephalitis Alliance. Their logos are affixed to the bottom of this communication. You can rest assured…

It’s time that we are seen and heard! The Foundation is honoured to hear the voice of our Ambassador, Jayden Liuzza. We believe that this is a more effective and powerful way for those of us affected by anti-NMDA to…